Related Experiment Videos

[Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms]

E Molina-Holgado1, A Areválo-Martín, J M Vela

  • 1Instituto Cajal. CSIC, Madrid, España.

Revista De Neurologia
|November 19, 2002
PubMed

Insights

Theiler's murine encephalomyelitis virus (TMEV) infection causes a chronic demyelinating disease. Immune responses targeting viral and self-antigens, alongside inflammatory cytokines, drive disease progression and neuronal damage.

Area of Science:

  • Neuroimmunology
  • Virology
  • Picornavirus research

Context:

  • Theiler's murine encephalomyelitis virus (TMEV) infection in susceptible animals leads to a paralytic syndrome.
  • This syndrome is characterized by chronic progressive demyelinating disease with perivascular immune cell infiltration in the central nervous system (CNS).
  • TMEV-induced demyelinating disease (TMEV IDD) pathogenesis involves virus-specific CD4+ T cells and autoimmune responses to myelin epitopes via epitope spreading.

Purpose:

  • To delineate pathogenic mechanisms underlying TMEV IDD, focusing on inflammation, demyelination, and axonal loss.
  • To emphasize the role of proinflammatory cytokines in sustaining inflammation and causing direct oligodendrotoxicity.
  • To present potential therapeutic strategies targeting cytokine modulation.

Summary:

  • TMEV IDD pathogenesis is driven by both viral clearance mechanisms and autoimmune responses.
  • Proinflammatory cytokines are crucial in perpetuating CNS inflammation and directly damaging oligodendrocytes, the myelin-producing cells.
  • Epitope spreading, where immune responses broaden to self-antigens, contributes significantly to the chronic nature of the disease.

Impact:

  • Understanding these mechanisms can inform the development of targeted therapies for TMEV IDD and potentially other demyelinating diseases.
  • Highlighting the dual role of immune responses (viral and autoimmune) provides insights into managing chronic inflammatory CNS conditions.
  • Identifying cytokine-dependent pathways offers therapeutic targets to mitigate neuroinflammation and preserve neuronal function.

Related Concept Videos